- Home
- RMCF vs QNME Comparison
RMCF vs QNME Comparison
Compare RMCF & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | QNME |
|---|---|---|
| Founded | 1981 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Integrated Freight & Logistics |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 14.1M |
| IPO Year | 2024 | 2024 |
Fundamental Metrics
Financial Performance| Metric | RMCF | QNME |
|---|---|---|
| Price | $0.90 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 90.0K | ★ 3.9M |
| Earning Date | 10-19-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.88 | ★ 47.83 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,432,352.00 | $5,850,681.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 111.79 |
| 52 Week Low | $0.66 | $0.26 |
| 52 Week High | $2.99 | $1.40 |
Technical Indicators
Market Signals| Indicator | RMCF | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 42.41 |
| Support Level | $0.81 | $0.29 |
| Resistance Level | $1.24 | $0.94 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 18.52 | 5.98 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.